(Q35176975)

6 August 2017

1 reference

title

Functional dyspepsia: evaluation and treatment (English)

1 reference

6 August 2017

Magnus Simrén

1

1 reference

PubMed ID

12858607

6 August 2017

Jan Tack

series ordinal

2

1 reference

6 August 2017

1 June 2003

1 reference

Gastroenterology Clinics of North America

6 August 2017

1 reference

6 August 2017

32

1 reference

6 August 2017

2

1 reference

6 August 2017

577-599

1 reference

Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Dyspepsia in England and Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

What is behind dyspepsia?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Functional gastroduodenal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

A survey of dyspepsia in Great Britain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Impaired accommodation of proximal stomach to a meal in functional dyspepsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Psychological factors and somatic symptoms in functional dyspepsia. A comparison with duodenal ulcer and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Role of impaired gastric accommodation to a meal in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Ambulatory gastrojejunal manometry in severe motility-like dyspepsia: lack of correlation between dysmotility, symptoms, and gastric emptying.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Predominant symptoms identify different subgroups in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Gastric emptying rate of solids in patients with nonulcer dyspepsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Importance of vagal input in maintaining gastric tone in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Responses to gastric distension in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

The proximal stomach and postprandial symptoms in functional dyspeptics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Visceral hypersensitivity: facts, speculations, and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Basic and clinical aspects of visceral hyperalgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Selective gastric hypersensitivity and reflex hyporeactivity in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Symptoms and visceral perception in severe functional and organic dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Association between H. pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Nutrient-specific modulation of gastric mechanosensitivity in patients with functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Abnormal sensitivity to duodenal lipid infusion in patients with functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Chemospecific alterations in duodenal perception and motor response in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Effect of inhibition of gastric acid secretion on antropyloroduodenal motor activity and duodenal acid hypersensitivity in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Measurement of gastrointestinal motility in the GI laboratory.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Small intestinal motor abnormalities in patients with functional dyspepsia demonstrated by ambulatory manometry

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS) [correction of (IBD)]

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Serotonergic mediation of postprandial colonic tonic and phasic responses in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Low vagal tone and antral dysmotility in patients with functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Autonomic function in patients with functional dyspepsia assessed by 24-hour heart rate variability

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Relations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Suppression of anger and gastric emptying in patients with functional dyspepsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Discriminant analysis of factors distinguishing patients with functional dyspepsia from patients with duodenal ulcer. Significance of somatization.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Impaired drinking capacity in patients with functional dyspepsia: relationship with proximal stomach function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Functional dyspepsia symptoms, gastric emptying and satiety provocative test: analysis of relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Impact of sex and psychological factors on the water loading test in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Clinical and pathophysiological characteristics of acute-onset functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: a multicentre study in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

American Gastroenterological Association medical position statement: evaluation of dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

AGA technical review: evaluation of dyspepsia. American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Dyspepsia management in primary care: a decision analysis of competing strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

The irritable bowel syndrome: long-term prognosis and the physician-patient interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

The influence of cisapride on gastric tone and the perception of gastric distension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Efficacy of cisapride therapy in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Antidepressants for functional gastrointestinal syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Effect of intranasal sumatriptan on gastric tone and sensitivity to distension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Alosetron does not affect the visceral perception of gastric distension in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Alosetron withdrawn from market

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Erythromycin enhances fasting and postprandial proximal gastric tone in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Perception of changes in wall tension of the proximal stomach in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Functional gastrointestinal disorders: psychological, social, and somatic features

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Psychotherapy in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900023-2

7 January 2021

10.1016/S0889-8553(03)00023-2

Identifiers

DOI

1 reference

release_vir6xo63vfc4vcu7cdw45rrhgq

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vir6xo63vfc4vcu7cdw45rrhgq

24 November 2022

mapped directly with Wikidata item

PubMed ID

12858607

1 reference

PubMed ID

12858607